The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action.
about
The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesicPreparation and characterization of propylthiouracil niosomes.Enhanced transdermal delivery of salbutamol sulfate via ethosomes.Ethosomes, binary ethosomes and transfersomes of terbinafine hydrochloride: a comparative study.Ultradeformable liposomes with terpenes for delivery of hydrophilic compound.Novel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach.Effect of surfactant mixtures on skin structure and barrier properties.Lipid Vesicles for the Skin Delivery of Diclofenac: Cerosomes vs. Other Lipid Suspensions.Investigation of the mechanism of enhanced skin penetration by ultradeformable liposomesNanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation.Vesicles as tools for the modulation of skin permeability.Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations.Elastic vesicles as topical/transdermal drug delivery systems.Nanoparticles for transcutaneous vaccination.Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: development, characterization, and performance evaluation.Vesicular carriers for dermal drug delivery.Drug delivery through the skin: molecular simulations of barrier lipids to design more effective noninvasive dermal and transdermal delivery systems for small molecules, biologics, and cosmetics.Nanoparticles through the skin: managing conflicting results of inorganic and organic particles in cosmetics and pharmaceutics.Skin permeation behavior of elastic liposomes: role of formulation ingredients.Current and emerging lipid-based systems for transdermal drug delivery.Preparation and characterization of diphtheria toxoid-loaded elastic vesicles for transcutaneous immunization.Preparation and formulation of transferosomes containing an antifungal agent for transdermal delivery: Application of Plackett-Burman design to identify significant factors influencing vesicle size.Deformable liposomes by reverse-phase evaporation method for an enhanced skin delivery of (+)-catechin.Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate.Elastic Liposomes for Topical and Transdermal Drug Delivery.Stabilization of reactive nitroxides using invasomes to allow prolonged electron paramagnetic resonance measurements.Enhanced skin deposition and delivery of voriconazole using ethosomal preparations.Liposomes can both enhance or reduce drugs penetration through the skinInfluence of the flexible liposomes on the skin deposition of a hydrophilic model drug, carboxyfluorescein: dependency on their composition
P2860
Q28834636-0462AEA2-0F71-469B-BCFF-63CFDD01A8ADQ33266201-257AD8F2-DDB3-4E40-8F0C-2F7506EE1E71Q33313608-4877345C-0FF9-4AEA-967F-7BD8D9F441E0Q34148624-033DFAA7-ACAD-4D73-8696-813A5A4CB6EAQ34291684-451B752A-6C48-47EC-A259-719A09FA3219Q34696447-343530FD-35C8-47ED-AFF0-657990045F28Q34751237-7D346F24-A04A-40B6-B511-871A46AA11A9Q35155299-ECBC8983-0503-4E98-A2EE-81558B274AECQ35223247-C83307AA-31AE-4375-A007-6E2E31579ED3Q35567800-DE2FBF66-1005-4B14-81ED-7A3A58BAA45BQ36985889-1AF7B837-2F81-4311-9507-B66C914E32F5Q37125441-4E8F5013-D282-4F58-A14B-D9BC5FB5AABAQ37168636-DA090530-EF8F-40A5-B906-354A2D6FEEA5Q37274692-0129DFE8-69BE-4448-874A-4D92BD2A01C3Q37360648-4534C631-C6F9-441D-AD17-9DD41A2F6084Q37537581-05E5BA51-2ABF-4928-A542-F759133D1C2BQ37877228-B9414BFC-8A3A-4A4A-A126-334281319B5DQ37880721-86ADCF89-8546-482D-A773-56DDF7E92E85Q38095492-29CE4040-554F-4329-925A-2C0B49FCB392Q38590272-66E3257D-F89F-4F92-96B4-8371959AEC32Q40062135-BCE71575-E66B-481E-A204-C4FE3F007972Q42432107-FD4FD328-2766-40EF-BD19-3D32D033FE21Q43483148-9ECB3CBF-6F47-423B-A82B-1717DDDDDA50Q44047766-DBF93795-57B8-4DA5-842A-CCE9A2EF9C4AQ51330850-E8DCE5D6-EF5F-4AA2-8D78-FF4F8CB66618Q52893585-9A36C507-D171-46E0-92B9-0B3742E91DF1Q53748960-6CFB7783-0D08-4898-837D-1EC8D832F764Q58763362-693BFAD8-4F86-4AB0-95D8-30934B8D7018Q58914571-6B87E999-0547-490F-9AC5-00AFC2072401
P2860
The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
The in vitro transport of perg ...... suggested mechanism of action.
@en
The in vitro transport of perg ...... suggested mechanism of action.
@nl
type
label
The in vitro transport of perg ...... suggested mechanism of action.
@en
The in vitro transport of perg ...... suggested mechanism of action.
@nl
prefLabel
The in vitro transport of perg ...... suggested mechanism of action.
@en
The in vitro transport of perg ...... suggested mechanism of action.
@nl
P1476
The in vitro transport of perg ...... suggested mechanism of action.
@en
P2093
Joke A Bouwstra
P Loan Honeywell-Nguyen
P304
P356
10.1016/S0168-3659(02)00415-7
P407
P577
2003-01-01T00:00:00Z